Davison, Niall J. http://orcid.org/0000-0002-9447-0825
Guthrie, Nicole L.
Medland, Sarah
Lupinacci, Paul
Nordyke, Robert J.
Berman, Mark A.
Funding for this research was provided by:
Better Therapeutics
Article History
Received: 31 October 2023
Accepted: 24 November 2023
First Online: 3 January 2024
Declarations
:
: Niall J. Davison and Sarah Medland were contracted consultants of Maple Health Group, who were paid for work related to the model and manuscript by the study sponsor (Better Therapeutics). Sarah Medland’s current affiliation is York Health Economics Consortium, United Kingdom. Nicole L. Guthrie and Mark A. Berman were employees of Better Therapeutics at the time of the study and received compensation in the form of equity units and stock options. Paul Lupinacci was a contracted consultant of the study sponsor (Better Therapeutics) and was paid for work related to the manuscript. Robert J. Nordyke has no conflicts of interest to declare.
: This study does not directly involve any human participants, human data, and/or human material. This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.